"Path to $100M revenue" Take a step back and realize this potential.
PME revenue is $164M last year and they are worth $23B
We have a tranche performance rights for $250M
Based on the latest refills exceeding targets, lets use 8 refills as the base calc.
30k prescriptions x $3,600 ($450 x 8) = $108m USD ($171,766,651 AUD)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $617.6M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 31.5¢ | $1.783M | 5.561M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 460766 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 19200 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |